In the high-risk group (low Klotho and high FGF23), the number needed to treat (NNT) with trandolapril to prevent one cardiovascular death or heart failure hospitalization event was nine, representing a 25% reduction compared to risk stratification based on FGF23 alone (NNT=12). The gene discussed is FGF23; the disease is heart failure.